Consolidated Planning Corp Thermo Fisher Scientific Inc. Transaction History

Consolidated Planning Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$508.46 - $591.13 $37,626 - $43,743	74 Added 2.71%	2,804 $1.46 Million
Q1 2023 May 04, 2023	BUY	$535.0 - $604.82 $49,220 - $55,643	92 Added 3.49%	2,730 $1.57 Million
Q4 2022 Feb 10, 2023	BUY	$484.71 - $571.37 $16,964 - $19,997	35 Added 1.34%	2,638 $1.45 Million
Q3 2022 Nov 04, 2022	SELL	$507.19 - $604.49 $507 - $604	-1 Reduced 0.04%	2,603 $1.32 Million
Q2 2022 Aug 12, 2022	BUY	$500.9 - $612.21 $1.3 Million - $1.59 Million	2,604 New	2,604 $1.42 Million
Q4 2021 Feb 11, 2022	SELL	$569.0 - $667.24 $104,127 - $122,104	-183 Closed	0 $0
Q3 2021 Nov 17, 2021	BUY	$509.53 - $609.78 $93,243 - $111,589	183 New	183 $105,000

2,829

334M

2.37M

2.75M

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $201B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

Get notified when there are updates to the investment portfolio of Consolidated Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Consolidated Planning Corp with notifications on news.